We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

CTI BioPharma Settles Investor Testing Info Row For $20M

Law360, New York (September 5, 2017, 5:25 PM EDT) -- CTI BioPharma Corp. and its executives will pay $20 million to a proposed class of investors for allegedly withholding information about patient deaths during clinical trials for a myelofibrosis drug, which...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Washington Western

Nature of Suit

850(Securities/Commodities)

Judge

Subscribers Only

Date Filed

February 12, 2016

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.